Autonomic imbalance, hypertension, and cardiovascular risk
Autonomic imbalance, hypertension, and cardiovascular risk
复制标题
DOI:
10.1016/s0895-7061(00)00228-4
复制
发表时间:
2000-06-01
影响因子:
3.2
通讯作者:
Julius, S
中科院分区:
文献类型:
--
作者:
Brook, RD;Julius, S
It is clear from many large randomized trials and from the metaanalyses published in the early 1990s1, 2 that medication treatment of hypertension can be fully protective in reducing stroke risk. Unfortunately, the cardioprotective value of blood pressure therapy is less encouraging. Only with the use of low-dose diuretic therapy in the elderly3 has the reduction in cardiac morbidity approached the expected derived benefit from blood pressure lowering. In general, hypertension treatment has been unable to satisfactorily reduce cardiac morbidity and mortality. 4Several theories have sought to explain this apparent incongruity between our ability to lower blood pressure yet not adequately improve hypertensionrelated cardiovascular risk. Suboptimal control of blood pressure itself may be a contributing factor. This is underscored by the National Health and Nutrition Examination Study (NHANES) data, 5 the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure (JNC VI), 6 and similar publications in other industrialized countries, such as in Canada. 7 Our failure to adequately control blood pressure cannot be explained by transient office-induced pressure elevations, 8 but is more likely due to a lack of physician aggressiveness. 9 This is despite strong evidence that aggressive therapy is both safe and can be particularly effective, as exemplified by patients with diabetes. 10 Alternatively, blood pressure medications themselves have been blamed. Most older drugs—diuretics and ß-blockers—disrupt and may worsen many cardiovascular-related metabolic factors, particularly lipids